<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-O596QE59</identifier><date>1999</date><creator>Borštnar, Simona</creator><creator>Čufer, Tanja</creator><creator>Rudolf, Zvonimir</creator><creator>Vrhovec, Ivan</creator><relation>documents/doc/O/URN_NBN_SI_doc-O596QE59_001.pdf</relation><relation>documents/doc/O/URN_NBN_SI_doc-O596QE59_001.txt</relation><format format_type="issue">1</format><format format_type="volume">33</format><format format_type="type">article</format><format format_type="extent">str. 43-53</format><identifier identifier_type="ISSN">1318-2099</identifier><identifier identifier_type="COBISSID">9752281</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-O596QE59</identifier><language>eng</language><publisher publisher_location="[Zagreb]">Croatian Medical Association - Croatian Society of Radiology</publisher><publisher publisher_location="Ljubljana">Slovenian Medical Society - Section of Radiology</publisher><source>Radiology and oncology (Ljubljana)</source><rights>InC</rights><subject language_type_id="slv">Breast neoplasms</subject><subject language_type_id="slv">dojke</subject><subject language_type_id="slv">Plasminogen activator inhibitor 1</subject><subject language_type_id="slv">Plasminogen activator inhibitor 2</subject><subject language_type_id="slv">Prognosis</subject><subject language_type_id="slv">prognoza</subject><subject language_type_id="slv">rak (medicina)</subject><subject language_type_id="slv">Recurrence</subject><subject language_type_id="slv">Urokinase</subject><subject language_type_id="slv">urokinaze</subject><subject language_type_id="slv">zdravljenje</subject><title>Napovedni pomen urokinaznega aktivatorja plazminogena in njegovih inhibitorjev pri bolnicah z rakom dojk</title><title>Prognostic relevance of urokinase plasminogen activator and its inhibitors in patients with breast cancer</title></Record>